“Safety and Efficacy of Apremilast Through 104 Weeks in Patients Swith Moderate-to-Severe Psoriasis Who Continued on Apremilast or Switched from Etanercept Treatment in the LIBERATE Study”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s32. Accessed April 13, 2025. https://skin.dermsquared.com/skin/article/view/117.